Ora J - Search Results

1

Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection.

Liguori C, Pierantozzi M, Spanetta M, Sarmati L, Cesta N, Iannetta M, Ora J, Mina GG, Puxeddu E, Balbi O, Pezzuto G, Magrini A, Rogliani P, Andreoni M, Mercuri NB. Liguori C, et al. Among authors: ora j. Brain Behav Immun. 2020 Aug;88:11-16. doi: 10.1016/j.bbi.2020.05.037. Epub 2020 May 19. Brain Behav Immun. 2020. PMID: 32416289 Free PMC article.

2

Effect of an additional dose of indacaterol in COPD patients under regular treatment with indacaterol.

Cazzola M, Segreti A, Stirpe E, Puxeddu E, Ora J, Rogliani P, Matera MG. Cazzola M, et al. Among authors: ora j. Respir Med. 2013 Jan;107(1):107-11. doi: 10.1016/j.rmed.2012.09.022. Epub 2012 Oct 18. Respir Med. 2013. PMID: 23083839 Free article. Clinical Trial.

3

A 6MWT index to predict O2 flow correcting exercise induced SpO2 desaturation in ILD.

Ora J, Calzetta L, Pezzuto G, Senis L, Paone G, Mari A, Portalone S, Rogliani P, Puxeddu E, Saltini C. Ora J, et al. Respir Med. 2013 Dec;107(12):2014-21. doi: 10.1016/j.rmed.2013.10.002. Epub 2013 Oct 10. Respir Med. 2013. PMID: 24161677 Free article.

4

Effect of indacaterol on arterial blood gases in patients suffering from acute exacerbation of COPD.

Rogliani P, Ora J, Ciaprini C, Senis L, Stirpe E, Cazzola M. Rogliani P, et al. Among authors: ora j. Respir Med. 2014 Feb;108(2):307-13. doi: 10.1016/j.rmed.2013.10.022. Epub 2013 Nov 5. Respir Med. 2014. PMID: 24238769 Free article. Clinical Trial.

5

Canakinumab for the treatment of chronic obstructive pulmonary disease.

Rogliani P, Calzetta L, Ora J, Matera MG. Rogliani P, et al. Among authors: ora j. Pulm Pharmacol Ther. 2015 Apr;31:15-27. doi: 10.1016/j.pupt.2015.01.005. Epub 2015 Feb 4. Pulm Pharmacol Ther. 2015. PMID: 25660162 Review.

6

Pharmacological assessment of the onset of action of aclidinium and glycopyrronium versus tiotropium in COPD patients and human isolated bronchi.

Rogliani P, Calzetta L, Ora J, Lipsi R, Segreti A, Matera MG, Cazzola M. Rogliani P, et al. Among authors: ora j. Eur J Pharmacol. 2015 Aug 15;761:383-90. doi: 10.1016/j.ejphar.2015.04.042. Epub 2015 May 5. Eur J Pharmacol. 2015. PMID: 25952728 Clinical Trial.

7

Olodaterol + tiotropium bromide for the treatment of chronic obstructive pulmonary disease.

Cazzola M, Rogliani P, Ora J, Matera MG. Cazzola M, et al. Among authors: ora j. Expert Rev Clin Pharmacol. 2015;8(5):529-39. doi: 10.1586/17512433.2015.1075389. Expert Rev Clin Pharmacol. 2015. PMID: 26294073 Review.

8

Searching for the synergistic effect between aclidinium and formoterol: From bench to bedside.

Cazzola M, Calzetta L, Ora J, Puxeddu E, Rogliani P, Matera MG. Cazzola M, et al. Among authors: ora j. Respir Med. 2015 Oct;109(10):1305-11. doi: 10.1016/j.rmed.2015.08.005. Epub 2015 Aug 13. Respir Med. 2015. PMID: 26303336 Free article. Clinical Trial.

9

Treatment options for moderate-to-very severe chronic obstructive pulmonary disease.

Cazzola M, Rogliani P, Ora J, Matera MG. Cazzola M, et al. Among authors: ora j. Expert Opin Pharmacother. 2016;17(7):977-88. doi: 10.1517/14656566.2016.1155555. Epub 2016 Mar 21. Expert Opin Pharmacother. 2016. PMID: 26894516 Review.

10

Dog allergen immunotherapy and allergy to furry animals.

Liccardi G, Salzillo A, Calzetta L, Ora J, Rogliani P. Liccardi G, et al. Among authors: ora j. Ann Allergy Asthma Immunol. 2016 Jun;116(6):590. doi: 10.1016/j.anai.2016.04.007. Ann Allergy Asthma Immunol. 2016. PMID: 27264567 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters